$CELG Headlines
Post# of 44843
Posted On: 05/19/2014 11:22:13 AM
$CELG Headlines
Higher rates are coming — here’s how you prepare
8:38 a.m. May 12, 2014
- Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap
4:03 p.m. April 29, 2014
- blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Sue Chang
What ‘Game of Thrones’ can teach you about money
8:30 a.m. April 5, 2014
- Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond'
8:32 a.m. April 2, 2014
- Shawn Langlois
Play-it-safe stock investors may take some risk on jobs
8:31 a.m. March 30, 2014
- Wallace Witkowski
Nasdaq pullback rife with opportunity
2:07 p.m. March 25, 2014
- The Trading Deck
44 stocks on takeover target radar: Morgan Stanley
12:48 p.m. March 25, 2014
- blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry
12:45 p.m. March 25, 2014
- Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin
10:40 a.m. March 24, 2014
- Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching?
5:08 p.m. March 21, 2014
- Russ Britt
The Nasdaq has a message to deliver
1:57 p.m. March 20, 2014
- The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan
4:16 p.m. March 14, 2014
- Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares
1:33 p.m. March 14, 2014
- Russ Britt
From every angle, technicals point to richer stocks
2:26 p.m. March 11, 2014
- The Trading Deck
Winning approval for new drugs may get harder, analyst warns
4:56 p.m. Feb. 28, 2014
- Russ Britt
The market puts a few feathers in its cap
2:58 p.m. Jan. 23, 2014
- The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap
5:41 p.m. Jan. 13, 2014
- blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views
1:19 p.m. Jan. 13, 2014
- MarketWatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5%
10:47 a.m. Jan. 13, 2014
- Victor Reklaitis
Bristol, AbbVie blood-cancer drug gets breakthrough designation
8:25 a.m. Today8:25 a.m. May 19, 2014
- Seeking Alpha
J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market
9:17 a.m. May 16, 2014
- Seeking Alpha
Thoughts On The Celgene Revlimid Markman Hearing
9:15 a.m. May 16, 2014
- Seeking Alpha
Hottest Healthcare Stocks Now – HMSY CYH VRTX CELG
1:30 p.m. May 14, 2014
- InvestorPlace.com
Celgene Needs to Clear the Cluster Zone
9:00 a.m. May 14, 2014
- RealMoney.com
Prothena: 4 Different Insiders Have Purchased Shares This Month
11:42 a.m. May 13, 2014
- Seeking Alpha
3 Stocks Reiterated As A Buy: COP, CELG, BIIB
2:44 p.m. May 12, 2014
- TheStreet.com
Will Patterson (PDCO) Disappoint this Earnings Season? - Analyst Blog
1:00 p.m. May 12, 2014
- Zacks.com
Visualizing Biotech P/E Compression and Why It's a Buy Signal
10:19 a.m. May 12, 2014
- TheStreet.com
2014 FDA Drug Approval Calendar
9:22 a.m. May 12, 2014
- TheStreet.com
UPDATE: Morgan Stanley Reiterates On Celgene Ahead Of Markman Hearing
8:07 a.m. May 12, 2014
- benzinga.com
Investor's Corner: How To Use The Big Cap 20
3:09 p.m. May 8, 2014
- Investors Business Daily
3 Stocks Advancing The Drugs Industry
1:02 p.m. May 8, 2014
- TheStreet.com
RBC Doctor Panel Picks in Drugs and Biotech
7:54 a.m. May 8, 2014
- 247WallSt.com
Fear Not, Biotech Stock 'Correction' Is Not a Bursting Bubble
10:18 a.m. May 7, 2014
- TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You?
10:11 a.m. May 7, 2014
- TheStreet.com
3 Stocks Reiterated As A Buy: MU, CAT, CELG
10:59 a.m. May 6, 2014
- TheStreet.com
Celgene: Do The Revlimid Polymorph And Use Patents Matter?
11:44 a.m. May 5, 2014
- Seeking Alpha
Biotech Sector Performance in April: Gilead Sciences Rising
9:49 a.m. May 2, 2014
- TheStreet.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs
6:30 a.m. May 2, 2014
- TheStreet.com
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
8:05 a.m. Today8:05 a.m. May 19, 2014
- GlobeNewswire
Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation
7:00 a.m. May 16, 2014
- PR Newswire - PRF
Celgene Announces Presentations of Investigational Studies in Solid
Tumor and Blood Cancers at ASCO 2014
5:19 p.m. May 14, 2014
- BusinessWire - BZX
Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver
9:31 a.m. May 14, 2014
- PR Newswire - PRF
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene
7:20 a.m. May 13, 2014
- PR Newswire - PRF
Celgene Prices $2.5 Billion of Senior Unsecured Notes
7:32 a.m. May 7, 2014
- BusinessWire - BZX
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma
9:15 a.m. May 6, 2014
- PR Newswire - PRF
Celgene Announces Offering of Senior Unsecured Notes
8:32 a.m. May 6, 2014
- BusinessWire - BZX
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene
8:00 a.m. May 5, 2014
- PR Newswire - PRF
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent
8:00 a.m. May 2, 2014
- PR Newswire - PRF
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver
9:31 a.m. May 1, 2014
- PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in May
8:30 a.m. April 25, 2014
- BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW
8:00 a.m. April 25, 2014
- PR Newswire - PRF
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other
Gastrointestinal Disorders
7:33 a.m. April 24, 2014
- BusinessWire - BZX
Upcoming Earnings Announcements -- Research on Superior Energy Services, Celgene, Penn National Gaming, and PerkinElmer
12:32 p.m. April 22, 2014
- PR Newswire - PRF
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA
8:00 a.m. April 14, 2014
- PR Newswire - PRF
BlackBerry CEO May Consider Exiting Handset Business; Celgene Corporation Favored over Natco in Pre-trial
12:43 a.m. April 10, 2014
- ACCESSWIRE
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma
1:20 p.m. April 8, 2014
- PR Newswire - PRF
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading
12:10 a.m. April 7, 2014
- ACCESSWIRE
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use
4:15 p.m. April 4, 2014
- PR Newswire - PRF
Higher rates are coming — here’s how you prepare
8:38 a.m. May 12, 2014
- Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap
4:03 p.m. April 29, 2014
- blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Sue Chang
What ‘Game of Thrones’ can teach you about money
8:30 a.m. April 5, 2014
- Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond'
8:32 a.m. April 2, 2014
- Shawn Langlois
Play-it-safe stock investors may take some risk on jobs
8:31 a.m. March 30, 2014
- Wallace Witkowski
Nasdaq pullback rife with opportunity
2:07 p.m. March 25, 2014
- The Trading Deck
44 stocks on takeover target radar: Morgan Stanley
12:48 p.m. March 25, 2014
- blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry
12:45 p.m. March 25, 2014
- Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin
10:40 a.m. March 24, 2014
- Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching?
5:08 p.m. March 21, 2014
- Russ Britt
The Nasdaq has a message to deliver
1:57 p.m. March 20, 2014
- The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan
4:16 p.m. March 14, 2014
- Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares
1:33 p.m. March 14, 2014
- Russ Britt
From every angle, technicals point to richer stocks
2:26 p.m. March 11, 2014
- The Trading Deck
Winning approval for new drugs may get harder, analyst warns
4:56 p.m. Feb. 28, 2014
- Russ Britt
The market puts a few feathers in its cap
2:58 p.m. Jan. 23, 2014
- The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap
5:41 p.m. Jan. 13, 2014
- blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views
1:19 p.m. Jan. 13, 2014
- MarketWatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5%
10:47 a.m. Jan. 13, 2014
- Victor Reklaitis
Bristol, AbbVie blood-cancer drug gets breakthrough designation
8:25 a.m. Today8:25 a.m. May 19, 2014
- Seeking Alpha
J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market
9:17 a.m. May 16, 2014
- Seeking Alpha
Thoughts On The Celgene Revlimid Markman Hearing
9:15 a.m. May 16, 2014
- Seeking Alpha
Hottest Healthcare Stocks Now – HMSY CYH VRTX CELG
1:30 p.m. May 14, 2014
- InvestorPlace.com
Celgene Needs to Clear the Cluster Zone
9:00 a.m. May 14, 2014
- RealMoney.com
Prothena: 4 Different Insiders Have Purchased Shares This Month
11:42 a.m. May 13, 2014
- Seeking Alpha
3 Stocks Reiterated As A Buy: COP, CELG, BIIB
2:44 p.m. May 12, 2014
- TheStreet.com
Will Patterson (PDCO) Disappoint this Earnings Season? - Analyst Blog
1:00 p.m. May 12, 2014
- Zacks.com
Visualizing Biotech P/E Compression and Why It's a Buy Signal
10:19 a.m. May 12, 2014
- TheStreet.com
2014 FDA Drug Approval Calendar
9:22 a.m. May 12, 2014
- TheStreet.com
UPDATE: Morgan Stanley Reiterates On Celgene Ahead Of Markman Hearing
8:07 a.m. May 12, 2014
- benzinga.com
Investor's Corner: How To Use The Big Cap 20
3:09 p.m. May 8, 2014
- Investors Business Daily
3 Stocks Advancing The Drugs Industry
1:02 p.m. May 8, 2014
- TheStreet.com
RBC Doctor Panel Picks in Drugs and Biotech
7:54 a.m. May 8, 2014
- 247WallSt.com
Fear Not, Biotech Stock 'Correction' Is Not a Bursting Bubble
10:18 a.m. May 7, 2014
- TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You?
10:11 a.m. May 7, 2014
- TheStreet.com
3 Stocks Reiterated As A Buy: MU, CAT, CELG
10:59 a.m. May 6, 2014
- TheStreet.com
Celgene: Do The Revlimid Polymorph And Use Patents Matter?
11:44 a.m. May 5, 2014
- Seeking Alpha
Biotech Sector Performance in April: Gilead Sciences Rising
9:49 a.m. May 2, 2014
- TheStreet.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs
6:30 a.m. May 2, 2014
- TheStreet.com
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
8:05 a.m. Today8:05 a.m. May 19, 2014
- GlobeNewswire
Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation
7:00 a.m. May 16, 2014
- PR Newswire - PRF
Celgene Announces Presentations of Investigational Studies in Solid
Tumor and Blood Cancers at ASCO 2014
5:19 p.m. May 14, 2014
- BusinessWire - BZX
Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver
9:31 a.m. May 14, 2014
- PR Newswire - PRF
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene
7:20 a.m. May 13, 2014
- PR Newswire - PRF
Celgene Prices $2.5 Billion of Senior Unsecured Notes
7:32 a.m. May 7, 2014
- BusinessWire - BZX
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma
9:15 a.m. May 6, 2014
- PR Newswire - PRF
Celgene Announces Offering of Senior Unsecured Notes
8:32 a.m. May 6, 2014
- BusinessWire - BZX
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene
8:00 a.m. May 5, 2014
- PR Newswire - PRF
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent
8:00 a.m. May 2, 2014
- PR Newswire - PRF
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver
9:31 a.m. May 1, 2014
- PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in May
8:30 a.m. April 25, 2014
- BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW
8:00 a.m. April 25, 2014
- PR Newswire - PRF
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other
Gastrointestinal Disorders
7:33 a.m. April 24, 2014
- BusinessWire - BZX
Upcoming Earnings Announcements -- Research on Superior Energy Services, Celgene, Penn National Gaming, and PerkinElmer
12:32 p.m. April 22, 2014
- PR Newswire - PRF
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA
8:00 a.m. April 14, 2014
- PR Newswire - PRF
BlackBerry CEO May Consider Exiting Handset Business; Celgene Corporation Favored over Natco in Pre-trial
12:43 a.m. April 10, 2014
- ACCESSWIRE
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma
1:20 p.m. April 8, 2014
- PR Newswire - PRF
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading
12:10 a.m. April 7, 2014
- ACCESSWIRE
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use
4:15 p.m. April 4, 2014
- PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼